Cholesterol Concentrations Improved in U.S. Adults From 2007 to 2018
FRIDAY, Aug. 26, 2022 (HealthDay News) — While lipid concentrations improved in the U.S. adult population from 2007 to 2018, there was variation in lipid control by race and ethnicity, according to a study published in the Aug. 23/30 issue of the J…
Learn MoreHeat Waves That Threaten Lives Will Be Common by 2100
FRIDAY, Aug. 26, 2022 (HealthDay News) — Life-threatening heat waves will become more common by the end of this century, according to a new study.A “dangerous” heat index — what the temperature feels like when humidity and air temperature are combine…
Learn MoreToo Few U.S. Cities Have Good Hurricane Evacuation Plans
FRIDAY, Aug. 26, 2022 (HealthDay News) — This year’s hurricane season has been quiet so far, but if and when it cranks up many American cities won’t be prepared to execute mass evacuations, a new study finds. After Hurricane Katrina slammed into New …
Learn MoreWife of California Congressman Died After Using Herbal Remedy
THURSDAY, Aug. 25, 2022 (HealthDay News) — Lori McClintock, the wife of Northern California congressman Tom McClintock, died late last year after taking white mulberry leaf, an herb used to treat diabetes, obesity, and high cholesterol, a recently …
Learn MoreLa vacuna contra la COVID de Pfizer ofrece una protección del 73 por ciento a los niños menores de 5 años
MIÉRCOLES, 24 de agosto de 2022 (HealthDay News) — La vacuna contra la COVID-19 modificada de Pfizer para su uso en niños de menos de 5 años tuvo una efectividad de un 73 por ciento al protegerlos de la infección durante el aumento de la ómicron de e…
Learn MoreLos refuerzos contra la COVID para las variantes más recientes podrían estar listos tras el Día del Trabajo
MIÉRCOLES, 24 de agosto de 2022 (HealthDay News) — La Administración de Biden planifica introducir unas dosis de refuerzo que se dirigen a las variantes ómicron poco después del Día del Trabajo, en un esfuerzo por proteger a los estadounidenses de un…
Learn MoreNew MS Treatment Shows Promise in Trial
THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found.The drug, called ublituximab, beat a standard oral medic…
Learn MoreU.S. College Students Face COVID-19-Related Stressors
THURSDAY, Aug. 25, 2022 (HealthDay News) — Financial hardship and bereavement are particularly important stressors tied to psychological distress among college students during the pandemic, according to a study published in the Oct. 1 issue of the …
Learn MoreU.S. Government Extends Baby Formula Waivers, Rebates for WIC Families
THURSDAY, Aug. 25, 2022 (HealthDay News) — To help parents who use government nutrition benefits cope with an ongoing shortage of baby formula, U.S. federal officials will extend a program giving them more choice at the grocery store.Families who buy…
Learn MoreReligion/Spirituality Tied to Better CV Health in African Americans
THURSDAY, Aug. 25, 2022 (HealthDay News) — Higher levels of religiosity/spirituality are associated with intermediate/ideal cardiovascular health on multiple Life’s Simple 7 (LS7) indicators among African Americans, according to a study published o…
Learn More